Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.29B |
| 2 |
Palo Alto Networks
PANW
|
+$524M |
| 3 |
Broadcom
AVGO
|
+$416M |
| 4 |
Qualcomm
QCOM
|
+$412M |
| 5 |
Tesla
TSLA
|
+$391M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.21B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Apple
AAPL
|
+$607M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Meta Platforms (Facebook)
META
|
+$523M |
Sector Composition
| 1 | Technology | 26.37% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.19% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Entravision Communication
EVC
$226M
| $7.92M | ﹤0.01% |
1,262,515
-27,564
| -2% | -$173K |
|
1827
Arbutus Biopharma
ABUS
$855M
| $7.89M | ﹤0.01% |
2,011,809
+892,198
| +80% | +$3.5M |
|
1828
Stoneridge
SRI
$228M
| $7.86M | ﹤0.01% |
370,279
-97,499
| -21% | -$2.07M |
|
|
TEN
1829
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $7.86M | ﹤0.01% |
795,296
-195,832
| -20% | -$1.94M |
|
1830
Kodiak Sciences
KOD
$489M
| $7.86M | ﹤0.01% |
98,223
-10,848
| -10% | -$868K |
|
|
VIVO
1831
DELISTED
Meridian Bioscience Inc
VIVO
| $7.83M | ﹤0.01% |
383,658
-184,311
| -32% | -$3.76M |
|
1832
Fiverr
FVRR
$881M
| $7.83M | ﹤0.01% |
+68,818
| New | +$7.83M |
|
1833
Scholastic
SCHL
$691M
| $7.82M | ﹤0.01% |
195,623
-32,559
| -14% | -$1.3M |
|
|
CELL
1834
DELISTED
PhenomeX Inc. Common Stock
CELL
| $7.79M | ﹤0.01% |
455,016
-16,034
| -3% | -$274K |
|
1835
Gates Industrial
GTES
$6.6B
| $7.76M | ﹤0.01% |
487,520
-23,417
| -5% | -$373K |
|
1836
Axcelis
ACLS
$2.69B
| $7.75M | ﹤0.01% |
123,505
-9,545
| -7% | -$599K |
|
1837
Marten Transport
MRTN
$953M
| $7.75M | ﹤0.01% |
460,169
-422,415
| -48% | -$7.11M |
|
|
GCP
1838
DELISTED
GCP Applied Technologies Inc.
GCP
| $7.75M | ﹤0.01% |
244,002
-17,328
| -7% | -$550K |
|
1839
Guess, Inc.
GES
$869M
| $7.72M | ﹤0.01% |
346,470
-31,405
| -8% | -$700K |
|
1840
Ligand Pharmaceuticals
LGND
$3.23B
| $7.71M | ﹤0.01% |
88,878
-6,784
| -7% | -$588K |
|
1841
FuelCell Energy
FCEL
$222M
| $7.69M | ﹤0.01% |
41,403
+3,272
| +9% | +$608K |
|
1842
Costamare
CMRE
$1.48B
| $7.69M | ﹤0.01% |
672,300
+31,594
| +5% | +$361K |
|
1843
Astrana Health
ASTH
$1.38B
| $7.69M | ﹤0.01% |
107,502
-10,384
| -9% | -$743K |
|
1844
Standard BioTools
LAB
$493M
| $7.66M | ﹤0.01% |
1,955,086
+23,251
| +1% | +$91.1K |
|
1845
Allegiant Air
ALGT
$1.19B
| $7.65M | ﹤0.01% |
44,686
-4,923
| -10% | -$843K |
|
1846
The Beauty Health Co
SKIN
$321M
| $7.65M | ﹤0.01% |
359,953
-220,885
| -38% | -$4.69M |
|
1847
Plains GP Holdings
PAGP
$3.7B
| $7.64M | ﹤0.01% |
753,858
-471,676
| -38% | -$4.78M |
|
1848
AZZ Inc
AZZ
$3.52B
| $7.62M | ﹤0.01% |
144,955
-7,984
| -5% | -$420K |
|
1849
ADT
ADT
$7.24B
| $7.61M | ﹤0.01% |
904,467
-317,144
| -26% | -$2.67M |
|
1850
CorVel
CRVL
$4.39B
| $7.59M | ﹤0.01% |
109,470
-6,516
| -6% | -$452K |
|